ProfileGDS4718 / 207589_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 28% 31% 34% 30% 28% 26% 34% 32% 34% 36% 28% 29% 25% 30% 33% 26% 28% 27% 27% 28% 30% 31% 31% 27% 28% 30% 29% 32% 25% 29% 29% 35% 25% 28% 25% 29% 27% 28% 28% 28% 24% 25% 24% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6203832
GSM549102patient 115, normal, homogenized [OPG study]4.4656128
GSM549104patient 119, normal, homogenized [OPG study]4.5751231
GSM549108patient 138, normal, homogenized [OPG study]4.7693434
GSM549119patient 077, normal, homogenized [OPG study]4.5340130
GSM549133patient 032, cancer, homogenized [OPG study]4.3833428
GSM549139patient 042, cancer, homogenized [OPG study]4.3487926
GSM549099patient 107, normal, homogenized [OPG study]4.7325134
GSM549109patient 139, normal, homogenized [OPG study]4.6398132
GSM549110patient 046, normal, homogenized [OPG study]4.7382434
GSM549114patient 063, normal, homogenized [OPG study]4.7510536
GSM549122patient 082, normal, homogenized [OPG study]4.4747628
GSM549134patient 033, cancer, homogenized [OPG study]4.4814629
GSM549136patient 036, cancer, homogenized [OPG study]4.2923125
GSM549140patient 044, cancer, homogenized [OPG study]4.5068530
GSM549111patient 047, normal, homogenized [OPG study]4.630833
GSM549113patient 057, normal, homogenized [OPG study]4.3113126
GSM549132patient 031, cancer, homogenized [OPG study]4.4359828
GSM549137patient 038, cancer, homogenized [OPG study]4.4185427
GSM549142patient 047, cancer, homogenized [OPG study]4.5245127
GSM549100patient 110, normal, homogenized [OPG study]4.4823928
GSM549107patient 135, normal, homogenized [OPG study]4.511130
GSM549115patient 068, normal, homogenized [OPG study]4.5322731
GSM549116patient 072, normal, homogenized [OPG study]4.5774331
GSM549120patient 078, normal, homogenized [OPG study]4.4047627
GSM549131patient 030, cancer, homogenized [OPG study]4.419928
GSM549118patient 074, normal, homogenized [OPG study]4.5384230
GSM549129patient 027, cancer, homogenized [OPG study]4.5118629
GSM549123patient 088, normal, homogenized [OPG study]4.6256932
GSM549124patient 006, cancer, homogenized [OPG study]4.3818225
GSM549126patient 015, cancer, homogenized [OPG study]4.4820329
GSM549128patient 025, cancer, homogenized [OPG study]4.4715729
GSM549103patient 117, normal, homogenized [OPG study]4.8275935
GSM549117patient 073, normal, homogenized [OPG study]4.3253625
GSM549138patient 041, cancer, homogenized [OPG study]4.4472728
GSM549141patient 045, cancer, homogenized [OPG study]4.296925
GSM549130patient 028, cancer, homogenized [OPG study]4.4989329
GSM549101patient 111, normal, homogenized [OPG study]4.4517427
GSM549105patient 128, normal, homogenized [OPG study]4.4750828
GSM549106patient 134, normal, homogenized [OPG study]4.3937328
GSM549112patient 048, normal, homogenized [OPG study]4.4584328
GSM549125patient 011, cancer, homogenized [OPG study]4.3173924
GSM549127patient 024, cancer, homogenized [OPG study]4.3357625
GSM549135patient 035, cancer, homogenized [OPG study]4.2651724